Open AccessRadiation recall dermatitis with dabrafenib and trametinib: A case report
Author(s) -
Mesut Yılmaz,
Uğur Çelik,
Seyhan Özakkoyunlu Hasçiçek
Publication year - 2020
Publication title -
world journal of clinical cases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.368
H-Index - 10
ISSN - 2307-8960
DOI - 10.12998/wjcc.v8.i3.522
Subject(s) - dabrafenib , trametinib , medicine , radiation therapy , recall , dermatology , melanoma , oncology , metastatic melanoma , cancer research , mapk/erk pathway , vemurafenib , linguistics , philosophy , kinase , biology , microbiology and biotechnology
Radiation recall dermatitis has been defined as the "recalling" by skin of previous radiation exposure in response to the administration of certain response-inducing drugs. Although the phenomenon is relatively well known in the medical world, an exact cause has not been documented.